EUVIMEDEUVIMED entdecken
Crossref

Tirzepatide protects against hepatic oxidative stress in high-fat induced obesity in male rats

Ashraf Jameel Alathary, Zahraa Jawad Kadhim

Maaen Journal for Medical Sciences · 15.08.2024 · 3 (3)

DOI: 10.55810/2789-9136.1053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Maaen Journal for Medical Sciences, online erschienen am 15.08.2024. Verfasst von Ashraf Jameel Alathary und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity is a prevalent health issue that affects people of all ages at a high rate. Tirzepatide (TZP) is a hypoglycemic medication that acts as a dual antagonist for both the GIP-1 and GIP receptors. Previous reports have shown that TZP treatment demonstrated substantial weight reduction as well as lipid-modulating effects in obese and overweight individuals.

Objective

The aim from this study is to examine the potential protective effect of TZP on oxidative stress status and HFD induced obesity in male rats.

Methods

This research employed a total of 28 adult male Sprague-Dawley rats. Normal control group involved seven rats fed a regular diet, while the other rats received a high-fat diet (HFD). Obese rats separated into three groups after eight weeks of HFD: obesity, tirzepatide (10 nmol/kg) s.c, and vehicle groups, and treated for four weeks. Data regarding body weight, blood glucose, and lipid profile, as well as the levels of SOD and MDS in the liver tissue were obtained.

Results

The results have demonstrated that TZP-treated obese rats exhibited significantly reduced body weight, blood glucose levels, TG and VLDL. Additionally, liver specimens from TZP group showed increased content of SOD enzyme compared to obese untreated rats.

Conclusion

Treating obese rats with TZP improved body weight, blood glucose lipid profile and elevating the level of the antioxidant defense.

Zitieren

APA

Alathary, A. J., & Kadhim, Z. J. (2024). Tirzepatide protects against hepatic oxidative stress in high-fat induced obesity in male rats. Maaen Journal for Medical Sciences, 3(3). https://doi.org/10.55810/2789-9136.1053

Vancouver

Alathary AJ, Kadhim ZJ. Tirzepatide protects against hepatic oxidative stress in high-fat induced obesity in male rats. Maaen Journal for Medical Sciences. 2024;3(3). doi:10.55810/2789-9136.1053

BibTeX
@article{Alathary2024,
  author = {Alathary, Ashraf Jameel and Kadhim, Zahraa Jawad},
  title = {Tirzepatide protects against hepatic oxidative stress in high-fat induced obesity in male rats},
  journal = {Maaen Journal for Medical Sciences},
  year = {2024},
  volume = {3},
  number = {3},
  doi = {10.55810/2789-9136.1053}
}
Kostenlos starten →